scorecardresearch
Add as a preferred source on Google
Friday, October 3, 2025
TopicNovo Nordisk

Topic: Novo Nordisk

In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

New Delhi: There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on...

Ozempic on steroids? Successor that could cut down weight in half the time coming soon

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its effectiveness in obesity management come out in 3 months.

On Camera

Why Modi’s supporters fear ‘proud Hindu’ MK Gandhi and venerate his murderer Godse

Every Gandhi Jayanti, we witness a contradiction in Hindutva position — PM Modi hails ‘beloved Bapu’ while his supporters attack and abuse him.

Nodal officers to fast-tracking NOCs, Kerala govt’s heeding investor concerns, and it means business

As many as 21 policy reforms are under implementation following Invest Kerala Global Summit, as LDF govt works to change perception that the state is not conducive to businesses.

Finnish giant ICEYE to build signature radar microsatellites in India, offers full control to govt

Company builds microsatellites that are smaller, faster, cheaper to produce. ICEYE will develop & launch micro-satellites, hand them over to India, which will have full control & sovereignty.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.